Login / Signup

Frequency and Risk Factor Analysis for Metronidazole-Associated Neurologic Adverse Events.

Se Ju LeeJinnam KimKi Hyun LeeJung Ah LeeChang Hyup KimJin Young AhnSu Jin JeongNam Su KuJun Yong ChoiJoon-Sup YeomSung-Ryeol KimJeong Ho Kim
Published in: Journal of general internal medicine (2023)
The number of reported metronidazole-associated neurological adverse events are increasing. Prolonged metronidazole treatment in patients with the aforementioned factors requires careful examination for neurological adverse events.
Keyphrases
  • risk factors
  • combination therapy
  • smoking cessation